A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity.
Marchal-Bras-Goncalves
R
R
Service de Recherches en Hémato-Immunologie, CEA-DSV-DRM, Hôpital Saint-Louis, Paris, France.
Rouas-Freiss
N
N
Connan
F
F
Choppin
J
J
Dausset
J
J
Carosella
E D
ED
Kirszenbaum
M
M
Guillet
J
J
D002478:Cells, Cultured; D002999:Clone Cells; D003001:Cloning, Molecular; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000502:physiology*; D004926:Escherichia coli; D006680:HLA Antigens / Q000276:immunology* / Q000494:pharmacology; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000276:immunology* / Q000494:pharmacology; D006801:Humans; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D016133:Polymerase Chain Reaction; D011993:Recombinant Fusion Proteins / Q000302:isolation & purification / Q000494:pharmacology*
D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D011993:Recombinant Fusion Proteins